Incidence of hepatocellular carcinoma after seroclearance is not reduced

Hepatology

Volumn 64, Issue 2, 2016, Pages 690-

  Tan, Chee Kiat ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

CANCER INCIDENCE; CANCER PATIENT; CONFIDENCE INTERVAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SEROLOGY; STATISTICAL ANALYSIS; VIRAL CLEARANCE;

EID: 84963745635     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28505     Document Type: Letter

References (2)

1. Correction for “Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus”, Hepatology 2015;62:1330.
2. Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 2010;51:1531-1537.